Johnson and Johnson’s vaccine trial has been paused. Now what?


After showing promising results Johnson and Johnson’s COVID-19 vaccine trial has been put on hold. You might wonder what this means for the race to find a vaccine.

Aidan Moller speaks with Paul Griffin, associate Professor of Medicine at the University of Queensland. He says that these recent ‘setbacks’ are protocol in clinical trials and believes we’re on track for a vaccine by early if not mid-next year.

Next, we hear from Stephen Duckett – Director of the Health Program at the Grattan Institute about what the road-map to recovery might entail.

(Visited 8 times, 1 visits today)
Download Audio

The Wire is produced in partnership by

Contributor Stations

Supporters and Program Distribution